| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36c2e2dff1900e1b35fd45052140dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6ef1e6f5747007e4d725e35de053c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_767fbd12f78507000211dce3e98fbe56 |
| publicationDate |
2010-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7674466-B2 |
| titleOfInvention |
Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells using antibodies that bind to ICAM-1 |
| abstract |
Methods for targeting and prolonging association of a selected drug to the luminal surface of pulmonary vascular endothelium of an animal are provided wherein a selected drug is administered to an animal in combination with a non-internalizable ICAM-1 antibody which binds to an antigen on the luminal surface of the pulmonary vasculature. This method is particularly useful in dissolution of fibrin clots or prevention of the intravascular coagulation in the pulmonary vasculature. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010151005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010285015-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8333973-B2 |
| priorityDate |
1999-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |